Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
3(23%)
Results Posted
0%(0 trials)
Terminated
1(8%)

Phase Distribution

Ph not_applicable
3
23%
Ph phase_3
3
23%
Ph phase_4
7
54%

Phase Distribution

0

Early Stage

0

Mid Stage

10

Late Stage

Phase Distribution13 total trials
Phase 3Large-scale testing
3(23.1%)
Phase 4Post-market surveillance
7(53.8%)
N/ANon-phased studies
3(23.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

3

trials recruiting

Total Trials

13

all time

Status Distribution
Active(4)
Completed(8)
Terminated(1)

Detailed Status

Completed8
Recruiting2
Active, not recruiting1
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
3
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Phase 33 (23.1%)
Phase 47 (53.8%)
N/A3 (23.1%)

Trials by Status

active_not_recruiting18%
not_yet_recruiting18%
recruiting215%
terminated18%
completed862%

Recent Activity

3 active trials
Showing 5 of 13
active_not_recruitingphase_4

Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics

NCT05757167
not_yet_recruitingnot_applicable

Tafenoquine Combinations for Improved Radical Cure Efficacy of Plasmodium Vivax

NCT07533136
recruitingphase_4

OPTImizing Malaria And HIV Treatment in a Shifting Landscape in Africa

NCT06967519
completednot_applicable

Impact of Malaria Mass Drug Administration on Malaria Prevalence in Under 15 Children and Pregnant Women

NCT07358767
recruitingphase_3

A Study to Find Out if a Combination of 3 Medicines for the Treatment of Malaria Works as Well and is as Safe and Tolerable as Combinations of 2 Medicines

NCT05951595
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT05757167Phase 4

Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics

Active Not Recruiting
NCT07533136Not Applicable

Tafenoquine Combinations for Improved Radical Cure Efficacy of Plasmodium Vivax

Not Yet Recruiting
NCT06967519Phase 4

OPTImizing Malaria And HIV Treatment in a Shifting Landscape in Africa

Recruiting
NCT07358767Not Applicable

Impact of Malaria Mass Drug Administration on Malaria Prevalence in Under 15 Children and Pregnant Women

Completed
NCT05951595Phase 3

A Study to Find Out if a Combination of 3 Medicines for the Treatment of Malaria Works as Well and is as Safe and Tolerable as Combinations of 2 Medicines

Recruiting
NCT06300970Phase 4

Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Treatment of Plasmodium Falciparum Malaria in Liberia

Completed
NCT04695197Phase 3

Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso

Completed
NCT05060198Not Applicable

Therapeutic Efficacy Study of AL and DP in Western Kenya

Completed
NCT02741024Phase 4

Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Uncomplicated Malaria in South Kivu, DR Congo

Completed
NCT02637128Phase 4

In Vivo Efficacy of Artemether-Lumefantrine and Artesunate-Amodiaquine for Uncomplicated P. Falciparum Malaria

Completed
NCT01728961Phase 4

Pharmacology of Antimalarial Therapy With or Without Antiretroviral Therapy

Terminated
NCT00393679Phase 3

Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Children

Completed
NCT00885287Phase 4

Interactions Between Artemether-lumefantrine and Antiretrovirals in HIV-patients With Uncomplicated Malaria in Tanzania

Completed

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13